7 results
Spironolactone for Pulmonary Arterial Hypertension
Researchers at the National Institutes of Health (NIH) Clinical Center are testing if spironolactone can be used to treat PAH. Spironolactone is a medication that can help with fluid retention, however it may also be beneficial to adults with PAH by controlling inflammation and improving blood vessel function in the lungs.
Learn More
COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): A Randomized Controlled Trial COVID-19 Adaptation and Response to Exercise (En español)
Researchers at the National Institutes of Health's (NIH) Clinical Center are looking for adult volunteers for a study on whether an aerobic exercise program benefits survivors of COVID-19. (En español)
Learn More
Famine from Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes
The National Institutes of Health (NIH) researchers are enrolling adult volunteers in a study investigating the role of Vitamin C in red blood cells of patients with type 2 diabetes. Findings may help improve future treatment and care of people with diabetes.
Learn More
Mediterranean-like Unprocessed (CLEAN-MED) Diet Intervention Study of the Gut Microbiome of Healthy Adults
A research study at the National Institutes of Health (NIH) is is investigating how dietary habits affect our intestinal microorganisms by studying the effects of Mediterranean-like unprocessed (CLEAN-MED) diet. Participants will be divided into two groups, depending on their interest in trying out the diet for 4 weeks or maintaining a new healthy diet over months, and will be provided with some foods. Participants will log the food they eat and answer questions about their diet throughtout the study. Food and research supplies and procedures are provided at no cost.
Learn More
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients with Systemic Lupus Erythematosus
People with systemic lupus erythematosus (SLE) are at risk of developing complications in their blood vessels. The risks increase for heart attacks or stroke. No medications have been effective at reducing this risk in people with lupus. Researchers at NIH are testing whether a drug (anifrolumab) can improve blood vessel function and reduce blood vessel inflammation in people with (SLE). Participants do not pay for tests, treatments, or procedures.
Learn More
Dietary Behavior Intervention
The risk of heart disease among African Americans is still common despite a greater understanding of the disease and better approaches to managing it. Healthy cooking and eating patterns can help reduce the risk of heart disease. But things like access to grocery stores and knowledge of good nutrition can affect these healthy patterns. Researchers at The National Institutes of Health want to see if community-based programs can help.
Learn More